Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population‐based cohort study in Sweden and Norway

Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients

(2018) Anna Ravn Landtblom et al.   LEUKEMIA

Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses

(2017) Srdan Verstovsek et al.   Journal of Hematology & Oncology

Does ruxolitinib prolong the survival of patients with myelofibrosis?

(2016) Francisco Cervantes et al.   BLOOD

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

(2016) H. K. Al-Ali et al.   HAEMATOLOGICA

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

(2016) H. K. Al-Ali et al.   HAEMATOLOGICA

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups

(2015) H. Joachim Deeg et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

(2015) A. M. Vannucchi et al.   HAEMATOLOGICA

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis

(2015) A. M. Vannucchi et al.   HAEMATOLOGICA

Estimating the loss in expectation of life due to cancer using flexible parametric survival models

(2013) Therese M-L Andersson et al.   STATISTICS IN MEDICINE

Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study

(2012) Malin Hultcrantz et al.   JOURNAL OF CLINICAL ONCOLOGY

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

(2011) Magnus Björkholm et al.   JOURNAL OF CLINICAL ONCOLOGY

The Myelofibrosis Symptom Assessment Form (MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis

(2009) Ruben A. Mesa et al.   LEUKEMIA RESEARCH

The completeness of the Swedish Cancer Register – a sample survey for year 1998

(2008) Lotti Barlow et al.   ACTA ONCOLOGICA

Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness

(2008) Inger Kristin Larsen et al.   EUROPEAN JOURNAL OF CANCER

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

(2008) F Cervantes et al.   LEUKEMIA